First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?
Crossref DOI link: https://doi.org/10.1186/s13046-016-0380-5
Published Online: 2016-06-30
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fabi, Alessandra
Malaguti, Paola
Vari, Sabrina
Cognetti, Francesco